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Contusion is a type of injury caused by a 
collision of the body with a blunt object followed by 
damage to the soft parts of the body, bone damage, 
bleeding and swelling. The tissue Injuries cause an 
inflammatory or inflammatory reaction, in which 
the inflammatory reaction is followed by pain 
(dolor), heat (kolor), red (rubor), swelling (tumor), 
and impaired function in the area around the 
wound (fungsiolesa). The Inflammatory reactions 
are the result of increased capillary permeability 
and migration of leukocytes to areas of inflamed 
tissue. The body's defense process against injury 
involves cells that infiltrate the wounded areas 
including neutrophils, macrophages, and 
lymphocytes. The body's response to inflammation 
is characterized by the release of neutrophils from 
the blood vessels which function as the first 
defense cells that play a role in phagocytosis of 
microorganisms and inflammatory cells in the 
wound. Contusion can be cured by giving anti-
inflammatory drugs that aim to relieve pain, slow 
and prevent the spread of the tissue destruction 
process.the  Anti-inflammatory drugs are classified 
into two, namely Non-Steroid Anti-inflammatory 
(NSAIDs) and Anti-inflammatory Steroids (AIS), a 
class of anti-inflammatory drugs that have the 
ability to suppress signs and symptoms of 
inflammation. The use of anti-inflammatory drugs 
in humans can cause side effects that are harmful 
to the body such as ulcers, cardiovascular diseases 
and osteoporosis, while fot the animals cause the 
difficulties due to the large variety of species. 
Therefore, herbal ingredients are developed, one of 
which is sernai (Wedelia biflora). Sernai has 
empirical benefits as a medicine for wounds and 
ulcers , sernai leaf water extracts as antipyretics, 
antitripanosoma, antimicrobials, antifungal, and 
anti-inflammatory agents. Sernai contains 
alkaloids, terpenoids, triterpenoids and flavonoids. 
The Flavonoid compounds can inhibit the release 
of arachidonic acid, secretion of lysozyme enzymes 
from neutrophil cells and endothelial cells and 
inhibit the proliferation phase and exudation phase 
of the inflammatory process. If the prostaglandin 
pathway is inhibited, the the occurrence of local 
blood vessel vasodilatation will reduces and so a 
leukocyte infiltration decreases, then it is replaced 
by macrophages that function to help endothelial 
cell formation and new blood vessels so that 
wound healing can take place quickly . 
 
MATERIALS & METHODS 
Sernai leaves were taken in Lamteube Mon 
Ara, Kuta Baro District, Aceh Besar. the making of 
EEDS was done with maceration method.  The rats 
were anesthetized with local EMLA anesthesia 
before treated. After the anesthesia reacted, the 
contusion was made by pressing the base of the 
rat's tail using 23 cm doyen intestinal forceps with a 
1 degree squeeze ratchet on the handle for 1 
minute 30 seconds, then released. Each group that 
has been bruised is treated as follows: P0 
treatment: negative control, P1 treatment: 
contusion with EEDS 10%,P2 treatment: contusion 
with EEDS 20%,P3 treatment: contusion with EEDS 
40%. The extract was given by applying evenly in 
the contusion area once a day according to dosage 
and the contusion area before being given 
treatment was measured. Then the observation 
was done for 8 days to see the extent of the wound 
by measuring the area of the contusion (length x 
width) using a caliper. The rat blood was collected 
through orbital sinus to calculate neutrophils. The 
Blood collection was carried out on day 0 before 
treatment, day 3 and day 6 after treatment. The 
data was tested using the One Way Analysis of 
Variance (ANOVA) method and continued with the 
Regression test. 
 
RESULTS AND DISCUSSION 
Tabel 1. Average ± SD number of neutrophils (%) of rats 
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The 0th day before being given contusion 
and EEDS treatment, the average percentage of rat 
neutrophils was between 24-25%. This result is in 
the normal range. The average normal percentage 
of rat neutrophils ranged from 6.2-26.7%. 
Therefore, this data becomes a base line to see 
whether there is an increasing or decreasing in 
neutrophils if the animal is induced by contusion 
and given EEDS. The results of the statistical, there 
was no significant differences (P> 0.05) between 
treatment groups with 0, 3 and 6 days. But, there 
was a tendency for increasing on day 3 with a 
higher percentage of neutrophils compared to the 
base line (number of neutrophils on day 0 that had 
not been given the contusion induction), namely, 
P0 (27, 16%), P1 (28.16%), P2 (27.66%), P3 
(30.00%). Furthermore, the percentage of 
neutrophils on day 6 was lower than day 3 and 
higher than day 0, namely, P0 (25.33%), P1 
(27.66%), P2 (27.33%) and P3 (28.00%). When 
compared to the base line showed an increase in 
the number of neutrophils starting on day 3 along 
with the inflammatory process due to bruising, 
then the number of neutrophils decreases on day 6 
compared to day 3. The Increased number of 
neutrophils on day 3 is affected by increased blood 
flow and blood capillary permeability followed by 
vasodilation during injury, so phagocytic cells such 
as neutrophils, macrophages, platelets and T 
lymphocytes migrate to the wound area. The 
number of inflammatory cells around the wound 
area is marked by an increased number of 
neutrophils, causing symptoms of swelling or 
edema. The wound healing process begins with 
increased in the number of neutrophils in the 
inflammatory phase, followed by the proliferation 
phase, which is the process of repairing the skin 
epithelial cells so that the wound become normal 
again. Remodeling phase aimed for maximizing 
and integrity of the wound. When the number of 
neutrophils decreases, the area of the contusion 
becomes smaller. In the EEDS with treatment 
groups, i.e P0 (without treatment), P1 (Piroxicam 
0.5%), P2 (EEDS 10%), P3 (EEDS 20%) and P4 
(EEDS 40%). On the third day the area of contusion 
in the group P0 (52.52 mm), P1 (30.86 mm), P2 
(23.12 mm), P3 (22.15 mm) and P4 (18.57 mm), 
whereas on the 6th day the area of contusion was 
in groups P0 (18.5 mm), P1 (5.15 mm), P2 (4.48 
mm), P3 (4.47 mm) and P4 (1.34 mm). EEDS with 
various concentrations can accelerate the 
inflammatory process for healing bruises. There is 
a response by shrinking the size of contusion with 
EEDS 10%, 20% and 40%, then the percentage of 
neutrophils in the 6th day will also decrease and be 
replaced immediately by macrophages to help the 
formation of new cells.The neutrophils increase in 
the inflammatory phase 0-5 days and decrease in 
the proliferation phase 3-14 days, the number of 
neutrophils in the proliferation phase is less 
because neutrophils have been replaced by 
macrophages. Macrophages support the formation 
of angiogenesis . However, the number of 
neutrophils has not approached the base line value 
because the measurement of neutrophil counts 
was only carried out until the 6th day, while the 
healing process averaged the reduction of the area 
of injury until the 8th day with the area of 
contusioan  in the P0 group (7.14 mm), P1 (1.95 
mm), P2 (0.88 mm), P3 (0.79 mm) and P4 (0.15 
mm), and in accordance with the conditions of 
contusion in the wound healing process is not 
perfect. The speed of wound healing can be 
influenced by substances contained in the drug 
given, such as the drug has the ability to improve 
healing by stimulating faster growth of new cells.  
Flavonoid content in EEDS is believed to be 
able to inhibit the release of arachidonic acid and 
the exudation phase of the inflammatory phase and 
also accelerate wound contraction and re-
epithelialization.. The Flavonoids also function as 
antimicrobials that function to kill bacteria. 
Increased prostaglandins will stimulate the pain 
nerves and increase the inflammatory response, if 
the inflammatory response persists and lasts 
longer will cause tissue damage, therefore 
inhibition of the cyclooxygenase pathway must be 
done to reduce the symptoms of inflammation. The 
role of saponins in EEDS as antibacterial by 
increasing the permeability of bacterial cell 
membranes so that hemolysis of bacterial, tannin 
and terpenoid cells has antioxidant activity that 
plays a role in capturing free radicals that can 
damage cell membranes and reduce inflammation 
of cells . 
The prostaglandin biosynthesis starting 
from stimulation of cells which causes damage to 
cell membranes, so that the enzyme phospholipase 
is activated to convert phospholipids to 
arachidonic acid and help the enzyme 
cyclooxygenase to produce prostaglandins. 
Prostaglandins are pain mediators that are specific 
for long-lasting pain. The active compounds 
contained in EEDS work to inhibit the release of 
serotonin and histamine which are chemical 
mediators to the site of inflammation, and work on 
the main mediator in inflammation which inhibits 
prostaglandin synthesis through inhibition of the 
synthesis of cyclooxygenase.The Stunted 
prostaglandin pathways will reduce vasodilation of 
blood vessels so that leukocyte infiltration 
decreases. With decreasing leukocyte infiltration, 
the inflammatory phase progresses rapidly so that 
the cell regeneration process can be formed 
immediately and the skin structure returns to 
normal. EEDS can accelerate wound healing by 
preventing inflammatory reactions, stimulating 
collagen synthesis, and vasodilation of blood 
vessels, and increasing the rate of angiogenesis. 
Thus this study shows that EEDS has the potential 
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as anti-inflammatory by accelerating the 
inflammatory process as well as analgesics by 
inhibiting prostaglandin synthesis 
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